Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
300255.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$20.36B
Close$
$-3.39
116.8% downside
Current Fair Value
116.8% downsideOvervalued by 116.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.36 Billion |
|---|---|
| Enterprise Value | $23.00 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.39 |
| Beta | 0.32 |
| Outstanding Shares | 919,060,878 |
Return
| Return on Equity | -29.10% |
|---|---|
| Return on Assets | -7.70% |
| Return on Invested Capital | -12.26% |
Valuation & Multiples
| P/E Ratio | -59.02 |
|---|---|
| PEG | 189.48 |
| Price to Sales | - |
| Price to Book Ratio | 20.15 |
| Enterprise Value to Revenue | 26.77 |
| Enterprise Value to EBIT | -91.65 |
| Enterprise Value to Net Income | -67 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 2.38 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
1,194 employees
CEO: Xiaodong Gao Hebei Changshan Biochemical Pharmaceutical Co., Ltd. operates within China, focusing on the entire lifecycle of heparin-based pharmaceuticals – from their initial research and development to manufacturing and sales. Their products are pr...